Doria, Manuel

Doria, Manuel was paid $2.30M by Medicaid between Jan 2018 and Nov 2024, across 166 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 18% of everything it billed.

Compared with peers

Next to other Anatomic Pathology & Clinical Pathology Physician providers in Illinois

Rank by total paid#30 of 398

Median peer was paid$66K

This provider vs. median35×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	31,590	$188K
2019	50,712	$294K
2020	34,670	$250K
2021	33,182	$403K
2022	62,951	$635K
2023	36,874	$300K
2024incomplete	43,231	$236K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	18%	6,975	5,420	$404K
80053	Comprehensive metabolic panel	6.2%	28,668	23,165	$144K
0202U	Oncology (prostate), multianalyte, gene expression profiling	5.0%	471	460	$116K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	4.5%	37,081	27,283	$105K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	4.5%	4,791	4,586	$103K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	4.5%	4,789	4,585	$103K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	3.7%	1,787	1,662	$85K
88305	Level IV - Surgical pathology, gross and microscopic examination	3.2%	2,645	2,365	$74K
84443	Thyroid stimulating hormone (TSH)	2.6%	7,513	7,032	$59K
88307		2.3%	831	770	$54K
0241U	Neonatal screening for hereditary disorders, genomic sequence analysis panel	2.3%	721	679	$53K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	2.2%	2,209	1,863	$52K

154 more codes

87086	Culture, bacterial; quantitative colony count, urine	1.9%	8,889	$44K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	1.8%	1,099	$42K
80048	Basic metabolic panel (calcium, ionized)	1.7%	9,388	$39K
87480		1.5%	2,818	$35K
87510		1.5%	2,815	$35K
82803		1.4%	2,890	$32K
83735		1.3%	8,782	$30K
87641		1.1%	1,119	$25K
87660		1.0%	2,987	$24K
83605		1.0%	4,494	$24K
87040		1.0%	2,559	$24K
82962		<1%	12,474	$22K
87081		<1%	7,009	$20K
88312		<1%	1,101	$19K
82330		<1%	2,185	$19K
84484		<1%	3,767	$18K
88141		<1%	1,986	$18K
80061	Lipid panel	<1%	5,057	$17K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	1,219	$17K
88341		<1%	327	$15K
87186		<1%	2,746	$15K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	2,030	$15K
85730		<1%	3,264	$14K
88342		<1%	882	$13K
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	1,044	$13K
86780		<1%	1,529	$13K
85610		<1%	5,996	$12K
83880		<1%	1,084	$11K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	215	$11K
88112		<1%	552	$11K
83036	Hemoglobin; glycosylated (A1C)	<1%	3,720	$11K
83690		<1%	3,223	$11K
86850		<1%	3,412	$10K
81025		<1%	4,642	$9K
80069		<1%	2,146	$9K
84439		<1%	2,084	$9K
81001		<1%	6,311	$9K
84100		<1%	3,966	$9K
88304		<1%	471	$9K
86901		<1%	3,686	$8K
86803		<1%	995	$8K
82607		<1%	1,322	$8K
86140		<1%	3,225	$7K
87088		<1%	1,178	$6K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	308	$6K
84466		<1%	1,469	$6K
86900		<1%	3,655	$6K
82728		<1%	1,590	$6K
80202		<1%	856	$6K
85384		<1%	1,730	$5K
87340		<1%	780	$5K
87581		<1%	242	$5K
87147		<1%	2,960	$5K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	191	$5K
84702		<1%	1,059	$5K
87070		<1%	1,486	$5K
82805		<1%	202	$5K
85379		<1%	1,221	$4K
87486		<1%	214	$4K
82570		<1%	1,884	$4K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	221	$4K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	580	$4K
85027		<1%	1,543	$4K
82784		<1%	639	$4K
81003		<1%	3,900	$4K
83540		<1%	1,358	$4K
83970		<1%	267	$4K
82746		<1%	680	$4K
82550		<1%	1,164	$3K
83615		<1%	1,145	$3K
85014		<1%	2,477	$3K
86038		<1%	371	$3K
83516		<1%	429	$2K
80047		<1%	525	$2K
85652		<1%	1,880	$2K
88173		<1%	59	$2K
87077		<1%	533	$2K
84703		<1%	621	$2K
87493		<1%	102	$2K
87205		<1%	1,057	$2K
86920		<1%	424	$2K
82565		<1%	836	$2K
82043		<1%	948	$2K
86762		<1%	379	$2K
G0103	Prostate cancer screening; prostate specific antigen test (psa)	<1%	189	$2K
86003		<1%	85	$2K
84550		<1%	799	$2K
85018		<1%	1,405	$1K
80074		<1%	78	$1K
80076		<1%	325	$1K
84478		<1%	518	$1K
84145		<1%	53	$960.68
84132		<1%	567	$941.67
84156		<1%	842	$932.77
84295		<1%	575	$923.62
86480		<1%	39	$921.97
82247		<1%	341	$887.03
82248		<1%	451	$872.80
87075		<1%	125	$865.56
85045		<1%	713	$850.82
87505		<1%	15	$793.05
84481		<1%	148	$708.44
82785		<1%	161	$656.29
86706		<1%	96	$619.38
85576		<1%	46	$583.67
84146		<1%	89	$541.62
88333		<1%	28	$534.03
84403		<1%	47	$511.92
82947		<1%	385	$508.19
87807		<1%	104	$507.19
82140		<1%	96	$435.82
82951		<1%	69	$432.66
83655		<1%	80	$418.16
80306		<1%	58	$347.11
86665		<1%	17	$316.80
80177		<1%	69	$307.86
85347		<1%	121	$307.57
86360		<1%	30	$302.58
83001		<1%	33	$248.03
86431		<1%	69	$229.46
86880		<1%	78	$223.75
86359		<1%	29	$223.14
87210		<1%	64	$200.94
82670		<1%	29	$200.62
85049		<1%	173	$197.20
80164		<1%	46	$196.89
84300		<1%	82	$196.26
82533		<1%	28	$184.57
86308		<1%	64	$153.06
83020		<1%	28	$146.82
86664		<1%	16	$140.80
86663		<1%	16	$137.12
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	12	$122.06
83930		<1%	46	$120.69
87102		<1%	29	$96.10
82627		<1%	17	$95.59
84480		<1%	29	$94.27
87045		<1%	14	$84.57
81015		<1%	66	$82.53
86200		<1%	15	$81.30
82272		<1%	80	$80.38
84270		<1%	13	$73.75
82950		<1%	34	$61.80
86403		<1%	16	$55.36
89051		<1%	16	$52.70
87184		<1%	12	$51.55
84157		<1%	37	$44.30
86376		<1%	12	$40.80
83935		<1%	17	$37.05
89050		<1%	17	$33.25
82945		<1%	16	$24.64
86592		<1%	12	$20.00
82009		<1%	13	$19.75
87046		<1%	14	$16.53

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.